B. Babu
About
B. Babu is a scholar working on Analytical Chemistry, Molecular Biology and Spectroscopy.
According to data from OpenAlex, B. Babu has authored 37 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Analytical Chemistry, 8 papers in Molecular Biology and 7 papers in Spectroscopy. Recurrent topics in B. Babu's work include Analytical Methods in Pharmaceuticals (11 papers), Analytical Chemistry and Chromatography (7 papers) and Pharmacological Effects and Assays (5 papers). B. Babu is often cited by papers focused on Analytical Methods in Pharmaceuticals (11 papers), Analytical Chemistry and Chromatography (7 papers) and Pharmacological Effects and Assays (5 papers). B. Babu collaborates with scholars based in India, Malaysia and Canada. B. Babu's co-authors include S. T. Narenderan, S. N. Meyyanathan, Praveen Thaggikuppe Krishnamurthy, Veera Venkata Satyanarayana Reddy Karri, Pavan Kumar Chintamaneni, Gowramma Byran, Karthik Yamjala, Navya Lakkappa, Kalirajan Rajagopal and Sung Hee Hwang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food Chemistry and RSC Advances.
In The Last Decade
B. Babu
36 papers receiving 450 citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| B. Babu India | 8 | 166 | 166 | 83 | 69 | 63 | 37 | 464 | ||
| S. T. Narenderan India | 7 | 217 1.3× | 192 1.2× | 89 1.1× | 88 1.3× | 72 1.1× | 24 | 507 | ||
| Xue Hou China | 11 | 332 2.0× | 242 1.5× | 115 1.4× | 118 1.7× | 121 1.9× | 19 | 604 | ||
| Xiangsheng Zhao China | 15 | 171 1.0× | 125 0.8× | 222 2.7× | 178 2.6× | 48 0.8× | 33 | 626 | ||
| Adriana F. Faria Brazil | 13 | 115 0.7× | 131 0.8× | 78 0.9× | 66 1.0× | 134 2.1× | 29 | 462 | ||
| Somchai Boonpangrak Thailand | 12 | 76 0.5× | 161 1.0× | 84 1.0× | 78 1.1× | 71 1.1× | 19 | 466 | ||
| Jian Xue China | 16 | 237 1.4× | 152 0.9× | 160 1.9× | 121 1.8× | 81 1.3× | 30 | 712 | ||
| Olga Shimelis United States | 11 | 144 0.9× | 199 1.2× | 107 1.3× | 26 0.4× | 115 1.8× | 17 | 490 | ||
| Zilei Chen China | 17 | 163 1.0× | 85 0.5× | 292 3.5× | 118 1.7× | 49 0.8× | 43 | 694 | ||
| Liling Wang China | 15 | 92 0.6× | 60 0.4× | 137 1.7× | 142 2.1× | 32 0.5× | 54 | 545 | ||
| Nayara Cristina Perez de Albuquerque Brazil | 10 | 98 0.6× | 81 0.5× | 90 1.1× | 57 0.8× | 188 3.0× | 19 | 511 |
Countries citing papers authored by B. Babu
Since
Specialization
Citations
This map shows the geographic impact of B. Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Babu more than expected).
Fields of papers citing papers by B. Babu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by B. Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Babu. The network helps show where B. Babu may publish in the future.
Co-authorship network of co-authors of B. Babu
This figure shows the co-authorship network connecting the top 25 collaborators of B. Babu. A scholar is included among the top collaborators of B. Babu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Babu. B. Babu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Babu, B., et al.. (2024). A Review on N-nitrosamine Impurity. Current Pharmaceutical Analysis. 20(1). 2–11.
2.
Meyyanathan, S. N., et al.. (2023). A novel chiral HPLC and LC-MS/MS method development for the triazole antifungal compound. Journal of Applied Pharmaceutical Science.
3.
Babu, B., et al.. (2023). Rational design of thiazolidine-4-one-gallic acid hybrid derivatives as selective partial PPARγ modulators: an in-silico approach for type 2 diabetes treatment. Journal of Biomolecular Structure and Dynamics. 43(2). 694–708.
4.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2022). Quantification of rosiglitazone in rat plasma and tissues via LC–MS/MS: Method development, validation, and application in pharmacokinetic and tissue distribution studies. Biomedical Chromatography. 36(5). e5326–e5326.
5.
Babu, B., et al.. (2021). QbD Approach For Anti-Cancer Drugs - A Review. Current Pharmaceutical Analysis. 18(3). 251–264.
6.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2021). Development and validation of a sensitive LC-MS/MS method for pioglitazone: application towards pharmacokinetic and tissue distribution study in rats. RSC Advances. 11(19). 11437–11443.
7.
Babu, B., et al.. (2021). Analytical quality by design-based LC-MS/MS method for the determination of Riociguat in its formulations. Journal of Applied Pharmaceutical Science.
8.
Babu, B., et al.. (2020). A stability-indicating LC–MS/MS method optimization for Pemetrexed through design of experiments: Identification and characterization of major oxidative degradation product. Journal of Pharmaceutical and Biomedical Analysis. 183. 113150–113150.
9.
Narenderan, S. T., S. N. Meyyanathan, & B. Babu. (2020). Review of pesticide residue analysis in fruits and vegetables. Pre-treatment, extraction and detection techniques. Food Research International. 133. 109141–109141.
10.
Babu, B., et al.. (2020). A NOVEL VALIDATED ANALYTICAL METHOD FOR THE ESTIMATION OF MIDODRINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATION BY LC-MS/MS. INDIAN DRUGS. 57(2). 41–44.
11.
Narenderan, S. T., et al.. (2020). A systematic approach for stability-indicating HPLC method optimization for Nilotinib bulk through design of experiments: Application towards characterization of base degradation products by mass spectrometry. Annales Pharmaceutiques Françaises. 79(4). 387–394.
12.
Gopinath, R., S. T. Narenderan, Mukesh Kumar, & B. Babu. (2020). A sensitive liquid chromatography–tandem mass spectrometry method for quantitative bioanalysis of fingolimod in human blood: Application to pharmacokinetic study. Biomedical Chromatography. 34(6). e4822–e4822.
13.
Narenderan, S. T., S. N. Meyyanathan, Veera Venkata Satyanarayana Reddy Karri, B. Babu, & Pavan Kumar Chintamaneni. (2019). Multivariate response surface methodology assisted modified QuEChERS extraction method for the evaluation of organophosphate pesticides in fruits and vegetables cultivated in Nilgiris, South India. Food Chemistry. 300. 125188–125188.
14.
Yamjala, Karthik, et al.. (2019). A simple sensitive UFLC-MS/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies. RSC Advances. 9(71). 41794–41802.
15.
Gopinath, R., S. T. Narenderan, Mukesh Kumar, & B. Babu. (2019). Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of lenalidomide in human plasma and its application on bioequivalence studies. Journal of Analytical Science & Technology. 10(1).
16.
Babu, B., et al.. (2018). Sensitive Analytical Liquid Chromatography-Tandem Mass Spectroscopy Method for the Estimation of Dexlansoprazole in Pharmaceutical Formulations. Journal of Applied Pharmaceutical Science. 8(7). 33–36.
17.
Babu, B., et al.. (2017). Development and validation of stability indicating liquid chromatography tan-dem mass spectrometry method for the determination of Dasatinib in bulk. International Journal of Research in Pharmaceutical Sciences. 8(4). 663–666.
18.
Byran, Gowramma, et al.. (2017). Synthesis of 2-(Bis (2-Chloroethyl)Amino)-N-(5-Substitutedphenyl)- 1,3,4- Thiadiazol-2-Yl)Acetohydrazide And Evaluation of Anticancer Activity. Current Bioactive Compounds. 14(3). 309–316.
19.
Lakkappa, Navya, Praveen Thaggikuppe Krishnamurthy, Karthik Yamjala, et al.. (2017). Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC–MS/MS method development. Journal of Pharmaceutical and Biomedical Analysis. 149. 457–464.
20.
Byran, Gowramma, Praveen Thaggikuppe Krishnamurthy, Kalirajan Rajagopal, & B. Babu. (2015). Synthesis of Some Novel 2-Azetidinones/4-Thiazolidinones Bearing 1, 3, 4- Thiadiazole Nucleus and Screening for its Anti-Imflammatory Activity. Letters in Drug Design & Discovery. 13(7). 676–683.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by S. T. Narenderan Breakdown of academic impact, for papers by Xue Hou Breakdown of academic impact, for papers by Xiangsheng Zhao Breakdown of academic impact, for papers by Adriana F. Faria Breakdown of academic impact, for papers by Somchai Boonpangrak Breakdown of academic impact, for papers by Jian Xue Breakdown of academic impact, for papers by Olga Shimelis Breakdown of academic impact, for papers by Zilei Chen Breakdown of academic impact, for papers by Liling Wang Breakdown of academic impact, for papers by Nayara Cristina Perez de Albuquerque